Boston Scientific Corpora...

AI Score

XX

Unlock

101.22
2.30 (2.33%)
At close: Apr 24, 2025, 3:59 PM
101.40
0.18%
After-hours: Apr 24, 2025, 07:54 PM EDT

Boston Scientific Revenue Breakdown

Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Cardiovascular Revenue 2.73B 2.64B 2.44B 2.29B 2.19B 2.24B 2.11B 2.13B 2.06B 2.07B 1.9B 1.27B 1.2B 1.26B 1.13B 1.01B 1B 834M 1.03B 1.2B 1.01B 1.03B 972M 971M 908M 965M 933M 883M 857M 889M 871M n/a 2.69B 1.79B 877M 835M 797M 812M 773M 779M 731M 738M 705M 728M 689M 742M 708M
Cardiovascular Revenue Growth +3.56% +7.85% +7.00% +4.58% -2.41% +6.11% -0.85% +3.05% -0.05% +8.62% +49.76% +6.19% -5.30% +11.87% +11.34% +1.20% +20.14% -18.71% -14.43% +18.60% -1.46% +5.56% +0.10% +6.94% -5.91% +3.43% +5.66% +3.03% -3.60% +2.07% n/a -100.00% +50.00% +104.10% +5.03% +4.77% -1.85% +5.05% -0.77% +6.57% -0.95% +4.68% -3.16% +5.66% -7.14% +4.80% n/a
MedSurg Revenue 1.48B 1.48B 1.41B 1.44B 1.34B 1.36B 1.28B 1.35B 1.26B 1.28B 1.16B 999M 917M 948M 860M 891M 825M 576M 774M 878M 845M 818M 766M 799M 746M 751M 711M 915M 827M 841M 794M n/a 2.33B 1.53B 733M 779M 697M 619M 574M 634M 593M 581M 551M 625M 581M 571M 521M
MedSurg Revenue Growth -0.27% +5.03% -2.01% +7.46% -1.40% +6.25% -5.54% +7.54% -1.41% +9.79% +16.52% +8.94% -3.27% +10.23% -3.48% +8.00% +43.23% -25.58% -11.85% +3.91% +3.30% +6.79% -4.13% +7.10% -0.67% +5.63% -22.30% +10.64% -1.66% +5.92% n/a -100.00% +51.96% +109.00% -5.91% +11.76% +12.60% +7.84% -9.46% +6.91% +2.07% +5.44% -11.84% +7.57% +1.75% +9.60% n/a

Revenue by Geography

Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Non-Us Revenue 5.82B 2.12B 4.98B 4.21B 1.9B 1.73B 3.76B 4.01B 1.88B
Non-Us Revenue Growth +174.86% -57.49% +18.19% +121.92% +9.90% -54.02% -6.33% +113.41% n/a
United States Revenue 8.43B 2.53B 1.51B 1B 2.26B 2.18B n/a n/a n/a
United States Revenue Growth +233.53% +67.51% +50.80% -55.83% +4.04% n/a n/a n/a n/a
Asia Pacific Revenue 2.4B 469M n/a n/a 395M 383M n/a n/a n/a
Asia Pacific Revenue Growth +411.73% n/a n/a n/a +3.13% n/a n/a n/a n/a
Emea Revenue 2.86B 5.11B n/a n/a 4.57B 4.29B n/a n/a n/a
Emea Revenue Growth -44.12% n/a n/a n/a +6.60% n/a n/a n/a n/a
Latin America And Canada Revenue 560M 3.27B n/a n/a 1.29B 5.54B n/a n/a n/a
Latin America And Canada Revenue Growth -82.88% n/a n/a n/a -76.65% n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 1.61B 1.56B 1.45B 1.36B 1.38B 1.24B 1.35B 1.22B 1.16B 1.13B 1.17B 1.06B 1.15B 1.07B 1.12B 1.02B 1.03B 984M 798M 978M 1.09B 1.01B 968M 869M 953M 870M 886M 860M 886M 800M 815M 794M 831M 772M 779M 716M 777M 729M 700M 668M
Selling, General, and Administrative Revenue Growth +3.20% +8.02% +6.01% -1.09% +11.03% -8.27% +11.44% +4.47% +2.74% -2.83% +9.91% -8.07% +8.16% -4.91% +10.01% -0.78% +4.37% +23.31% -18.40% -10.44% +7.91% +4.55% +11.39% -8.81% +9.54% -1.81% +3.02% -2.93% +10.75% -1.84% +2.64% -4.45% +7.64% -0.90% +8.80% -7.85% +6.58% +4.14% +4.79% n/a
Research and Development Revenue 459M 407M 383M 366M 363M 356M 359M 337M 330M 339M 335M 319M 320M 310M 298M 276M 286M 315M 242M 300M 309M 306M 280M 280M 288M 289M 275M 261M 264M 254M 244M 235M 256M 232M 222M 210M 244M 221M 220M 192M
Research and Development Revenue Growth +12.78% +6.27% +4.64% +0.83% +1.97% -0.84% +6.53% +2.12% -2.65% +1.19% +5.02% -0.31% +3.23% +4.03% +7.97% -3.50% -9.21% +30.17% -19.33% -2.91% +0.98% +9.29% 0.00% -2.78% -0.35% +5.09% +5.36% -1.14% +3.94% +4.10% +3.83% -8.20% +10.34% +4.50% +5.71% -13.93% +10.41% +0.45% +14.58% n/a